Literature DB >> 3536500

Antimicrobial chemotherapy of chlamydial infection: where next?

G L Ridgway.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3536500     DOI: 10.1007/BF02017703

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  21 in total

1.  Antichlamydial activity of quinolone carboxylic acids.

Authors:  C Heppleston; S Richmond; J Bailey
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

2.  In vitro activity of norfloxacin against Chlamydia trachomatis.

Authors:  H Meier-Ewert; G Weil; G Millott
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

3.  Activity of the newer quinolones against Chlamydia trachomatis.

Authors:  R J Van Roosbroeck; D R Provinciael; D L Van Caekenberghe
Journal:  Br J Vener Dis       Date:  1984-10

4.  In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.

Authors:  H Meier-Ewert; G Weil; G Millott
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis.

Authors:  W R Bowie; J S Yu; H D Jones
Journal:  Sex Transm Dis       Date:  1986 Apr-Jun       Impact factor: 2.830

6.  In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.

Authors:  R B Jones; G L Ridgway; S Boulding; K L Hunley
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

7.  Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis.

Authors:  R L Sweet; J Schachter; M O Robbie
Journal:  JAMA       Date:  1983-11-18       Impact factor: 56.272

8.  In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.

Authors:  T F Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

9.  Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results.

Authors:  J F Darne; G L Ridgway; J D Oriel
Journal:  Br J Vener Dis       Date:  1982-04

10.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  Br J Vener Dis       Date:  1978-04
View more
  7 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.

Authors:  J Retsema; A Girard; W Schelkly; M Manousos; M Anderson; G Bright; R Borovoy; L Brennan; R Mason
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme).

Authors:  A Bianchi; C Scieux; C M Salmeron; I Casin; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 6.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

7.  In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.

Authors:  J Fung-Tomc; J V Desiderio; Y H Tsai; G Warr; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.